19 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
to incentivize De Backer to join Vir at a pivotal time CEO sign-on arrangements designed with consideration of industry practices and alignment
DEF 14A
VIR
Vir Biotechnology Inc
6 Apr 20
Definitive proxy
4:52pm
of Directors determines appropriate. Additional grants may occur periodically in order to specifically incentivize executives with respect to achieving certain
10-K
tmgw8hp4bg
26 Mar 20
Annual report
4:08pm
DRS/A
1zwrj63f 0q
7 Aug 19
Draft registration statement (amended)
12:00am
424B4
lc79vmimd1dwvn1r cx8
11 Oct 19
Prospectus supplement with pricing info
5:31pm
DRS
4b3rzj276upv8j6f
27 Jun 19
Draft registration statement
12:00am
S-1
ghci 7q2spvflk0
3 Sep 19
IPO registration
4:40pm
S-1/A
t9a hs4a9ty5r18h
30 Sep 19
IPO registration (amended)
6:12am
8-K
EX-99.2
c9bld2 bx
6 Jul 20
Our mission is to create a world without infectious disease
6:32am
10-Q
xwoce
19 Nov 19
Quarterly report
4:06pm
- Prev
- 1
- Next